Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TheStaphylococcus aureusNetwork Adaptive Platform Trial Protocol: New Tools for an Old Foe

19 Jun 2022

Abstract excerpt

Staphylococcus aureus bloodstream (SAB) infection is a common and severe infectious disease, with a 90-day mortality of 15%-30%. Despite this, <3000 people have been randomized into clinical trials of treatments for SAB infection. The limited evidence base partly results from clinical trials for SAB infections being difficult to complete at scale using traditional clinical trial methods. Here we provide the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antifungal resistance and susceptibility
Share to Antimicrobial Resistance in Staphylococcus
Share to Bacterial Identification and Susceptibility Testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35717634
DOI: 10.1093/cid/ciac476

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

TheStaphylococcus aureusNetwork Adaptive Platform Trial Protocol: New Tools for an Old FoePMID 35717634Read ↗

Early Oral Antibiotic Switch in Staphylococcus aureus Bacteraemia: The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Early Oral Switch ProtocolSemantic proximity Read ↗

The West Africa Lassa fever Consortium pre-positioned protocol for a Phase II/III adaptive, randomised, controlled, platform trial to evaluate multiple Lassa fever therapeuticsSemantic proximity Read ↗

Identification and validation of clinical phenotypes in Staphylococcus aureus bloodstream infection and their association with mortality (FEN-AUREUS study)Semantic proximity Read ↗

The I-SPY COVID Adaptive Platform Trial for COVID-19 Acute Respiratory Failure: Rationale, Design and OperationsSemantic proximity Read ↗

Determining the return on investment of a global adaptive platform trial for critically ill patients during COVID-19: A value of implementation analysis in low- and middle-income countries and globallySemantic proximity Read ↗

Determining the return on investment of a global adaptive platform trial for critically ill patients during COVID-19: A value of implementation analysis in low- and middle-income countries and globallySemantic proximity Read ↗

The acid response network of Staphylococcus aureusSemantic proximity Read ↗

Impact upon clinical outcomes of translation of PNA FISH-generated laboratory data from the clinical microbiology bench to bedside in real timeSemantic proximity Read ↗

Methodological Analysis of Bias Risks in Adaptive Multi-Arm Platform Trials: A Case-Series from Three COVID-19 StudiesSemantic proximity Read ↗

Pragmatic management of Panton–Valentine leukocidin-associated staphylococcal diseasesSemantic proximity Read ↗

Impact of Accelerate Pheno and BacT/Alert Virtuo on Clinical Processes and Outcomes in Patients with Sepsis and Concurrent Gram-Negative BacteremiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.